{"tool_name":"pbcmc","contents":["biotools","bioschemas"],"fetched_metadata":{"biotools":{"id":"pbcmc","home":"http://bioconductor.org/packages/release/bioc/html/pbcmc.html","license":"GPL-2.0","summary":"Package that characterizes uncertainty assessment on gene expression classifiers (molecular signatures), based on a permutation test. To achieve this goal, synthetic simulated subjects are obtained by permutations of gene labels. Then, each synthetic subject is tested against the corresponding subtype classifier to build the null distribution. Thus, classification confidence measurement can be provided for each subject, to assist physician therapy choice.","addition_date":"2017-01-17T15:00:26Z","last_update_date":"2024-11-25T15:27:55.532174Z","tool_type":["Command-line tool","Library"],"version":["1.2.2"],"collections":["BioConductor"]},"bioschemas":{"name":"pbcmc","home":"https://bio.tools/pbcmc","license":"GPL-2.0","version":"1.2.2","summary":"Package that characterizes uncertainty assessment on gene expression classifiers (molecular signatures), based on a permutation test. To achieve this goal, synthetic simulated subjects are obtained by permutations of gene labels. Then, each synthetic subject is tested against the corresponding subtype classifier to build the null distribution. Thus, classification confidence measurement can be provided for each subject, to assist physician therapy choice.","tool_type":"sc:SoftwareApplication"}}}